Search results for:
upadacitinib
upadacitinib
| Drug Name |
Form |
Strength |
ARHS |
Blue Ridge |
Caldwell |
Chatham |
Johnston |
Lenoir |
Medical Center |
Nash |
Pardee |
Rex |
Rockingham |
Southeastern |
Wayne |
Youth Behavioral Health |
| Upadacitinib |
TABLET, EXTENDED RELEASE, ORAL |
45 mg |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Last updated: Oct. 7, 2025
UNC Health
System Formulary Restriction:
RESTRICTED to the following:
Caution – Category 1: Antineoplastic Hazardous Medication, see below for exposure mitigation strategies